Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Donald R Mattison"'
Autor:
Yannick Fortin, James A G Crispo, Deborah Cohen, Douglas S McNair, Donald R Mattison, Daniel Krewski
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174379 (2017)
Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser c
Externí odkaz:
https://doaj.org/article/1c923f1f96eb41378ac3c43623bbc447
Autor:
James A G Crispo, Allison W Willis, Dylan P Thibault, Yannick Fortin, Harlen D Hays, Douglas S McNair, Lise M Bjerre, Dafna E Kohen, Santiago Perez-Lloret, Donald R Mattison, Daniel Krewski
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150621 (2016)
Elderly adults should avoid medications with anticholinergic effects since they may increase the risk of adverse events, including falls, delirium, and cognitive impairment. However, data on anticholinergic burden are limited in subpopulations, such
Externí odkaz:
https://doaj.org/article/387d9a62b1124eef935a0f5f29a2423f
Autor:
Xiaoxia Yang, Suzanne M Morris, Jeffery M Gearhart, Christopher D Ruark, Merle G Paule, William Slikker, Donald R Mattison, Benedetto Vitiello, Nathan C Twaddle, Daniel R Doerge, John F Young, Jeffrey W Fisher
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106101 (2014)
The widespread usage of methylphenidate (MPH) in the pediatric population has received considerable attention due to its potential effect on child development. For the first time a physiologically based pharmacokinetic (PBPK) model has been developed
Externí odkaz:
https://doaj.org/article/b5b645e24fba41e9a37210a41f624b02
Autor:
James A. G. Crispo, Nawal Farhat, Yannick Fortin, Santiago Perez-Lloret, Lindsey Sikora, Rebecca L. Morgan, Mara Habash, Priyanka Gogna, Shannon E. Kelly, Jesse Elliott, Dafna E. Kohen, Lise M. Bjerre, Donald R. Mattison, Renée C. Hessian, Allison W. Willis, Daniel Krewski
Publikováno v:
Brain Sciences, Vol 14, Iss 8, p 776 (2024)
Reports suggest possible risks of adverse cardiovascular reactions, including heart failure, associated with non-ergot dopamine agonist (DA) use in Parkinson’s disease (PD). The objectives of our review were to evaluate the risk of heart failure an
Externí odkaz:
https://doaj.org/article/5b855239f24d4b4c81665d3438f25662
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Replacement Therapy, Leigh Miles Jackson, Ruth M. Parker, Donald R. Mattison
The U.S. Food and Drug Administration (FDA) has approved dozens of hormone therapy products for men and women, including estrogen, progesterone, testosterone, and related compounds. These products have been reviewed for safety and efficacy and are in
Publikováno v:
Global Epidemiology, Vol 4, Iss , Pp 100088- (2022)
Externí odkaz:
https://doaj.org/article/dc6a91e2dfba46f69345b1409a55fa84
Autor:
Mohamed Kadry Taher, Abdallah Alami, Christopher A. Gravel, Derek Tsui, Lise M. Bjerre, Franco Momoli, Donald R. Mattison, Daniel Krewski
Publikováno v:
JGH Open, Vol 5, Iss 7, Pp 778-784 (2021)
Abstract Background and Aim Quinolones are a potent and globally popular group of antibiotics that are used to treat a wide range of infections. Some case reports have raised concern about their possible association with acute hepatic failure (AHF).
Externí odkaz:
https://doaj.org/article/f648ed5d6f94484781b582132ade90b0
Autor:
Nawal Farhat, Nicholas Birkett, Nisrine Haddad, Yannick Fortin, Franco Momoli, Shi Wu Wen, Andreas Wielgosz, Doug S. McNair, Donald R. Mattison, Daniel Krewski
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 3, Pp 191-203 (2020)
Abstract Background The clinical implications of potential interactions between proton pump inhibitors (PPIs) and clopidogrel have been debated for over a decade. Objective We assessed the association between combined clopidogrel–PPI treatment and
Externí odkaz:
https://doaj.org/article/67b2c20142b54146ab62d5d9b9a87309
Publikováno v:
British Journal of Clinical Pharmacology.
Publikováno v:
Journal of the American Pharmacists Association. 62:42-48
Objective To describe the widespread use of compounded bioidentical hormone therapies (cBHT). To define the term clinical utility and present why there is insufficient evidence to support the overall clinical utility of cBHT products. To recommend ac